Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
SGR-1505 by Schrodinger for Splenic Marginal Zone B-Cell Lymphoma: Likelihood of Approval
SGR-1505 is under clinical development by Schrodinger and currently in Phase I for Splenic Marginal Zone B-Cell Lymphoma. According to...
SGR-1505 by Schrodinger for Primary Mediastinal B-Cell Lymphoma: Likelihood of Approval
SGR-1505 is under clinical development by Schrodinger and currently in Phase I for Primary Mediastinal B-Cell Lymphoma. According to GlobalData,...
SGR-1505 by Schrodinger for Refractory Chronic Lymphocytic Leukemia (CLL): Likelihood of Approval
SGR-1505 is under clinical development by Schrodinger and currently in Phase I for Refractory Chronic Lymphocytic Leukemia (CLL). According to...
SGR-1505 by Schrodinger for Relapsed Chronic Lymphocytic Leukemia (CLL): Likelihood of Approval
SGR-1505 is under clinical development by Schrodinger and currently in Phase I for Relapsed Chronic Lymphocytic Leukemia (CLL). According to...
SGR-1505 by Schrodinger for Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma): Likelihood of Approval
SGR-1505 is under clinical development by Schrodinger and currently in Phase I for Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma). According to GlobalData,...
SGR-1505 by Schrodinger for Follicular Lymphoma: Likelihood of Approval
SGR-1505 is under clinical development by Schrodinger and currently in Phase I for Follicular Lymphoma. According to GlobalData, Phase I...
SGR-1505 by Schrodinger for Burkitt Lymphoma: Likelihood of Approval
SGR-1505 is under clinical development by Schrodinger and currently in Phase I for Burkitt Lymphoma. According to GlobalData, Phase I...